论文部分内容阅读
Objective:To elucidate its pharmacological activities and medicinal potential of extract of Etlingera elatior (E. elatior).Methods: Phytochemical screening of the flower extract was done to determine the phytochemical in the extract. The pharmacological study included the determination of antimicrobial activity and minimum inhibitory concentration(MIC) of metabolic flower extract. The antimicrobial activity of the extract was tested against medically important bacterial, yeast and fungal strains. Apart from that, the methanolic extract ofE. elatior flower was further testedin vivo toxicity using the brine shrimp lethality test. Moreover, the flower extract was qualitatively screened for their free radical scavenging activity by 2, 2-diphenyl-1-picrylhydrazyl radical (DPPH) assay.Results:The extract was effective on tested microorganisms andMIC values were in the range of1.563-50.000 mg/mL. The brine shrimp lethality test exhibited no significant toxicity (LC50 = 2.52 mg/mL) againstArtemia salina. TheE. elatior flower extract with highLC50 value signified that this plant is not toxic to humans. While the phytochemical screening of the flower extract revealed the presence of the following compounds: flavonoids, terpenoids, saponin, tannins and carbohydrates whereas, alkaloids, anthraquinone and reducing sugars were absent. The concentration of the flower extract required for50% inhibition ofDPPH radical scavenging effect (IC50) were9.14 mg/mL and8.08 mg/mL for butylated hydroxytoluene8.08 mg/mL.Conclusions:These findings indicate that the extract ofE. elatior flower possesses pharmacological properties and potential to develop natural products based pharmaceuticals products.